Soligenix
SNGX
#10223
Rank
$16.23 M
Marketcap
$1.61
Share price
-1.23%
Change (1 day)
-49.69%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -$12.37 Million USD

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -$9.35 Million USD a decrease over its 2023 earnings that were of -$7.61 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$12.37 Million32.32%
2024 -$9.35 Million22.96%
2023 -$7.61 Million-45.74%
2022 -$14.01 Million11.88%
2021 -$12.53 Million-32.37%
2020 -$18.52 Million83.18%
2019 -$10.11 Million11.57%
2018 -$9.06 Million19.29%
2017 -$7.6 Million33%
2016 -$5.71 Million-19.7%
2015 -$7.12 Million5.16%
2014 -$6.77 Million
2010 -$7.64 Million26.12%
2009 -$6.06 Million75.1%
2008 -$3.46 Million-45.38%
2007 -$6.33 Million-22.84%
2006 -$8.2 Million66.15%
2005 -$4.94 Million-16.65%
2004 -$5.93 Million13.28%
2003 -$5.23 Million-11.88%
2002 -$5.94 Million-59.44%
2001 -$14.63 Million378.18%
2000 -$3.06 Million-38.53%
1999 -$4.98 Million-18.43%
1998 -$6.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Cleveland BioLabs
CBLI
-$2.76 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$0.16 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$9.10 B-73,673.72%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
$11.85 B-95,920.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$32.39 B-262,014.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-$41.77 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-$18.16 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$1.77 B-14,426.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel